SCHEMBL8285174

SCHEMBL8285174

CCCC(=O)c1cc(C)c2c(=O)cc(Nc3ccccc3)n(-c3ccccc3)c2n1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDE11A Q9HCR9 1/20 0.43
CSF1R P07333 1/20 0.37
KDM4E B2RXH2 4/20 0.36
HPGD P15428 4/20 0.36
HSD17B10 Q99714 3/20 0.36
POLB P06746 1/20 0.36
HTT P42858 1/20 0.36
MAPT P10636 3/20 0.35
ALDH1A1 P00352 2/20 0.35
TP53 P04637 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
GAA P10253 3/20 0.34
MAPK1 P28482 1/20 0.34
GFER P55789 1/20 0.34
THRB P10828 1/20 0.34
TSHR P16473 1/20 0.34
MAPK10 P53779 1/20 0.34
GSK3B P49841 1/20 0.33
P2RY12 Q9H244 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8285228 0.94 PDE11A (0.42) PDE11ACSF1RKDM4EHPGDHSD17B10
SCHEMBL8285167 0.93 PDE11A (0.41) PDE11ACSF1RKDM4EHPGDHSD17B10
SCHEMBL8287518 0.92 PDE11A (0.44) PDE11ACSF1RKDM4EHPGDHSD17B10
SCHEMBL5872175 0.87 PDE11A (0.47) PDE11ACSF1RKDM4EHPGDHSD17B10
SCHEMBL8285181 0.87 PDE11A (0.42) PDE11ACSF1RKDM4EHPGDHSD17B10
SCHEMBL8286396 0.87 PDE11A (0.44) PDE11ACSF1RKDM4EHPGDHSD17B10
SCHEMBL5871541 0.86 PDE11A (0.46) PDE11ACSF1RKDM4EHPGDHSD17B10
SCHEMBL8286372 0.86 CSF1R (0.47) PDE11ACSF1RKDM4EHPGDHSD17B10
SCHEMBL8287397 0.85 PDE11A (0.46) PDE11ACSF1RKDM4EHPGDHSD17B10
SCHEMBL8287393 0.85 PDE11A (0.46) PDE11AKDM4EHPGDPOLBHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed